Pharmaceutical Executive - Pharmaceutical news and analysis. Pharma management, sales, marketing & finance

Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial
ARCHIVED WEBCASTS

Featured Q&A- Clinical Portals: Balancing Sponsor and Site Perspectives
A wrapup of the discussions at CBI's 3rd Summit on Clinical Trial Investigator Portals

Meet 2011's Emerging Pharma Leaders
VIEW PDF: Can these 30 trendsetters build competitive scale from scarcity?

PODCAST: Listen to audio interviews with 7 of the Emerging Pharma Leaders
sponsored by:

2011 Pharm Exec 50

Ranks the world's largest pharmaceutical companies by global sales of prescription drugs.
sponsored by:

Pharma Country Reports
Market reports on pharma developments worldwide
sponsored by:

Featured Jobs

More Jobs

New & Noteworthy

Brand of the Year: Humira

Rich data on the clinical side, combined with flexible marketing and outreach to payers, have pushed Humira to the top ranks of powerhouse drugs...

Copay Cards and Coupons: Letting the Facts Get in the Way

Mason Tenaglia offers empirical defense of coupons and copay offset programs.

Pharma 2012: Hard Times Before the Harvest

The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.

The Pro-Patient Cometh

How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all?

More Selected Features

Europe

Here's to a Happier New Year?

Europe Tackles 'Advertising in Disguise' Fears

Does a German Launch Make Sense?

Strategic Acquisition: A CEO's View

Sir Michael Rawlins: Regulation and Reputation

Visit the Pharmaceutical Executive Europe Page

Regulatory

Essential Questions for Essential Benefits

New Year, New Issues

The Payoff for Payers

Spotlight on OTCs

The Drug Shortages Struggle

More Regulatory

Deals

Pharm Exec's 2012 Pipeline Report

30 Years of Pharma: Perspective in Numbers, Part 3

30 Years of Pharma: Perspective in Numbers, Part 1

30 Years of Pharma: Perspective in Numbers, Part 2

Pharm Exec's 10th Annual Industry Audit

More Deals

Technology

iPad Apps: Are You Content with your Content?

Innovating Around Innovation

Bridging the Hidden Hurdle in Cancer Cures

Pharma and Social Media: Ready to Make Nice?

Complex Biologics: The View from Teva

More Technology

Unmet Need in the Migraine Space?

HBA 2012 Woman of the Year: Thinking Beyond the Box

UK Reacts to AZ Job Cuts

Biogen Idec: The Patriots of Biotechs

Government-Funded Research: Is It That Different?

PCORI, Priorities, and Politics

More Blog Posts

Special ReportMarylyn DonahueMenopause Drugs
Data Analytics Reid PaulPredictive Modeling and Pharmacovigilance
RegulatoryAmy RitterFDA Encourages Whistleblowers
Guest Columnist Angie DrakulichBring Manufacturing Back, Orders Obama

Survey

More Marketing

More Sales

PHARM EXEC GLOBAL DIGEST

Have you read the latest issue of Pharmaceutical Executive Digest Europe yet?
Click here if you haven't.Click here to receive the Digest into your inbox every week.

Whitepapers

Increasing Planning Efficiency in Clinical Development

How Customer Analytics Improve Profitability

Customer Intimacy: The Pharma Challenge

SAS® for Marketing Strategy and Planning

UPS Survey Unveils Healthcare Supply Chain Trends

More Whitepapers

SPONSORED LINKS